What is Regenxbio's net change in cash?

Regenxbio (RGNX) reported net change in cash of -$19.24M in Q1 2026.

How has Regenxbio's net change in cash changed year-over-year?

Regenxbio's net change in cash decreased by 126.5% year-over-year, from $72.58M to -$19.24M.

What is the long-term trend for Regenxbio's net change in cash?

Over 2 years (2021 to 2023), Regenxbio's net change in cash has grown at a 188.8% compound annual growth rate (CAGR), from $7.48M to -$62.43M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Regenxbio RGNX Net Change in Cash

Net Change in Cash at other companies

Regeneron PharmaceuticalsREGN

-$153.1M-125%

Sarepta Therapeutics, Inc.SRPT

-$336.83M+60.9%

BiogenBIIB

$392.2M+108%

BioMarin PharmaceuticalsBMRN

$1.76B+1,562%

EyePoint, Inc. EYPT

-$24.11M-65.7%

Ultragenyx PharmaceuticalRARE

-$247M-449%

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's net change in cash?: Regenxbio (RGNX) reported net change in cash of -$19.24M in Q1 2026.
How has Regenxbio's net change in cash changed year-over-year?: Regenxbio's net change in cash decreased by 126.5% year-over-year, from $72.58M to -$19.24M.
What is the long-term trend for Regenxbio's net change in cash?: Over 2 years (2021 to 2023), Regenxbio's net change in cash has grown at a 188.8% compound annual growth rate (CAGR), from $7.48M to -$62.43M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.